Literature DB >> 15805812

Multimodal brain monitoring in the neurological intensive care unit: where does continuous EEG fit in?

Katja Elfriede Wartenberg1, Stephan A Mayer.   

Abstract

Continuous EEG (cEEG) is a vital component of patient monitoring in the neurologic intensive care unit, allowing the intensivist to diagnose nonconvulsive seizure activity. Though still in its infancy, Fourier-transformed cEEG data are also increasingly being used in ICUs to monitor global cerebral activity and cortical function. In conjunction with other components of multimodality neurologic monitoring, including intracranial pressure, cerebral blood flow, brain tissue oxygen tension monitoring, transcranial Doppler, and microdialysis monitoring, cEEG provides unique data regarding the electrical activity of the brain. The main challenge for clinicians and researchers will be to understand how these different aspects of multimodality monitoring relate to each other, and how physiologic variables such as blood pressure, osmolality, and temperature can be manipulated to optimize cerebral function and tissue survival in the setting of acute injury.

Entities:  

Mesh:

Year:  2005        PMID: 15805812     DOI: 10.1097/01.wnp.0000154918.51389.b6

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  3 in total

Review 1.  Continuous electroencephalogram monitoring in critically ill patients.

Authors:  Nathalie Jette; Lawrence J Hirsch
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

2.  Compressed EEG pattern analysis for critically ill neurological-neurosurgical patients.

Authors:  A K Shah; R Agarwal; J R Carhuapoma; J A Loeb
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

3.  Quantitative EEG correlates of low cerebral perfusion in severe stroke.

Authors:  Jennifer Diedler; Marek Sykora; Thomas Bast; Sven Poli; Roland Veltkamp; Patricio Mellado; Thorsten Steiner; André Rupp
Journal:  Neurocrit Care       Date:  2009       Impact factor: 3.210

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.